Ultrasound-Guided Diffuse Optical Tomography for Predicting and Monitoring Neoadjuvant Chemotherapy of Breast Cancers: Recent Progress

Ultrason Imaging. 2016 Jan;38(1):5-18. doi: 10.1177/0161734615580280. Epub 2015 Apr 16.

Abstract

In this manuscript, we review the current progress of utilizing ultrasound-guided diffuse optical tomography (US-guided DOT) for predicting and monitoring neoadjuvant chemotherapy (NAC) outcomes of breast cancer patients. We also report the recent advance on optical tomography systems toward portable and robust clinical use at multiple clinical sites. The first patient who has been closely monitored before NAC, at day 2, day 8, end of first three cycles of NAC, and before surgery is given as an example to demonstrate the potential of US-guided DOT technique.

Keywords: breast cancer treatment monitoring; dual-modalities; near infrared imaging; ultrasound; ultrasound-guided optical imaging.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Breast Neoplasms / diagnosis*
  • Breast Neoplasms / diagnostic imaging
  • Breast Neoplasms / drug therapy*
  • Chemotherapy, Adjuvant
  • Female
  • Humans
  • Neoadjuvant Therapy*
  • Tomography, Optical / methods*
  • Treatment Outcome
  • Ultrasonography, Mammary / methods*